Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Manuel Muñoz-Torres

Comparison of a Soluble Co-Formulation of Insulin Degludec/Insulin Aspart vs Biphasic Insulin Aspart 30 in Type 2 Diabetes: A Randomised Trial

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2012English

Ketoconazole Therapy: Hormonal and Clinical Effects in Non-Tumoral Hyperandrogenism

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
1994English

Related publications

Insulin Degludec Aspart: The First Co-Formulation of Insulin Analogues

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2014English

15 Years of Experience With Biphasic Insulin Aspart 30 in Type 2 Diabetes

Drugs in R and D
Pharmacology
2018English

Use of Biphasic Insulin Aspart 30 in Type 2 Diabetes Treatment: Expert Panel Recommendations

Turkish Journal of Endocrinology and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Initiation of Biphasic Insulin Aspart in a Patient Failing Basal Insulin Treatment

European Endocrinology
EndocrineEndocrinologyMetabolismAutonomic SystemsDiabetes
2010English

Fiasp: A New Faster-Acting Insulin Aspart Formulation for Diabetes

Prescriber
Pharmacology
2017English

Faster-Acting Insulin Aspart Provides Faster Onset and Greater Early Exposure vs Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus

Pediatric Diabetes
Internal MedicinePediatricsEndocrinologyPerinatologyChild HealthMetabolismDiabetes
2017English

Budget Impact Analysis of Biphasic Insulin Aspart in the Treatment of Type 2 Diabetes Mellitus in Malaysia: A Public Payer Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Safety and Effectiveness of Biphasic Insulin Aspart 30 in Different Age-Groups: A1chieve Sub-Analysis

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2013English

Continuous Subcutaneous Insulin Infusion (CSII) of Insulin Aspart Versus Multiple Daily Injection of Insulin Aspart/Insulin Glargine in Type 1 Diabetic Patients Previously Treated With CSII

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy